Sponsored by:

Altis Labs raises $25M for CT AI tool

AuntMinnie.com staff writers
Sep 21, 2026
Cash

Toronto-based Altis Labs has raised $25 million to expand use of its AI device IPRO for generating survival predictions in oncology clinical trials. 

IPRO is designed to generate survival predictions from routinely acquired CT scans to help drug developers detect treatment effects earlier than conventional imaging endpoints, the firm said. The new financing with be used to scale commercial deployment with biopharmaceutical partners, Altis noted. 

The round was co-led by OrbiMed and Qiming Venture Partners USA, with participation from Innovation Endeavors, Benchstrength, Fusion Fund, and the Cancer Breakthrough Fund, among others.

 

Latest in CT
Ai Logo
a2z Radiology secures FDA clearance for CT AI device
September 21, 2026
Imaging that comes to the patient with SOMATOM On.site
Sponsored
Imaging that comes to the patient with SOMATOM On.site
August 10, 2026
Ai Brain
AI boosts brain aneurysm detection on CT angiography
September 17, 2026
Heart 1
CCTA links neighborhood income to atherosclerosis
September 15, 2026
Related Stories
This figure shows fused I-124 evuzamitide positron emission tomography (PET)/computed tomography (CT) images from patients without amyloidosis and from patients with ATTR cardiac amyloidosis, early ATTR cardiac amyloidosis, light chain cardiac amyloidosis, gelsolin-mediated amyloidosis, and systemic organ amyloid. The columns represent radiological transaxial, sagittal, and coronal views except for the last row middle and far right columns, which are coronal projections. The blue asterisks represent physiological activity (tracer activity in the stomach and esophagus). The arrowheads represent pathological uptake. Note the small amount of cardiac uptake in the basal septum and the basal lateral walls (likely early ATTR cardiac amyloidosis), splenic uptake and pleural uptake in light chain amyloidosis, and cardiac and kidney uptake in gelsolin-mediated amyloidosis. The bright yellow color represents more tracer uptake.
Molecular Imaging
Bayer's PET agent meets endpoints in phase III cardiac amyloidosis study
Graph Arrow Up
Breast
Lancet Oncology: Global breast cancer cases could surge to 3.5M by 2050
Brain
Radiation Oncology/Therapy
ASTRO: Lu-177 dotatate shows promise for treating meningioma patients
Cardiac imaging you can trust, now within reach with SOMATOM go.Top
Sponsor Content
Cardiac imaging you can trust, now within reach with SOMATOM go.Top
More in CT
a2z Radiology secures FDA clearance for CT AI device
By AuntMinnie.com staff writers
The software analyzes abdominopelvic CT images acquired with or without intravenous contrast in adults 22 and older.
September 21, 2026
Ai Logo
Koning Breast CT System receives Australian TGA approval
By AuntMinnie.com staff writers
The system can now be sold in Australia, with Brisbane Radiology being the first Australian provider to purchase the system.
September 18, 2026
Australian Flag 400
AI boosts brain aneurysm detection on CT angiography
By Will Morton
AI preferentially detected smaller aneurysms (< 3 mm), while radiologists more often identified larger aneurysms (3 to 5 mm and > 5 mm).
September 17, 2026
Ai Brain
CCTA links neighborhood income to atherosclerosis
By Will Morton
The relationship between socioeconomic disparities and imaging-defined coronary atherosclerosis on CCTA has not been fully understood.
September 15, 2026
Heart 1
Chest CT muscle attenuation predicts future bone density loss
By Will Morton
Muscle and bone loss commonly coexist with aging, but potential links between paraspinal muscle and thoracic vertebral bone mineral density loss remain poorly understood
September 15, 2026
Study overview. (A) Volumetric segmentation of the paraspinal musculature was performed for 1,316 participants. (B) Manual segmentation was performed, the results were compared with the volumetric segmentation results, and the Dice score and the intersection over union were calculated. (C) The three-dimensional segmentations from T1 through T10 were individually extracted and combined into a single volume for analyses. (D) Muscle volume and median muscle attenuation were derived from the segmentation volumes. (E) Analyses were performed to assess the correlation of the paraspinal muscle attenuation and volume with the bone mineral density and the ability to predict vertebral fractures. NIFTI = Neuroimaging Informatics Technology Initiative, 3D = three-dimensional.
CT visualizes leadless pacemaker encapsulation
By Amerigo Allegretto
CT findings could guide risk stratification and treatment strategies for pacemakers.
September 11, 2026
Pacemaker Heart 400 (1)
Elucid nets $55M in funding round
By AuntMinnie.com staff writers
The financing brings Elucid's total funding to approximately $185 million.
September 2, 2026
Cash
AI cuts chest CT reporting time
By Will Morton
Exploratory modeling suggested an approximate reduction of 0.5 full-time equivalent radiologist workload.
September 1, 2026
Example of AI-assisted pulmonary nodule detection and longitudinal volumetric assessment in a 65-year-old woman with peripheral arterial disease, a 24-pack-year smoking history, emphysema, and a family history of lung cancer. An incidental 8.5-mm right lower lobe pulmonary nodule is identified at CT angiography of the abdomen in July 2022 but does not receive follow-up. Subsequent imaging demonstrates interval growth, and CT-guided biopsy confirms stage IA lung adenocarcinoma. Contrast-enhanced axial chest CT images obtained on February 2, 2024, before robotic-assisted thoracoscopic segmentectomy, show a 12.1-mm spiculated right lower lobe pulmonary nodule. (A) Conventional contrast-enhanced axial chest CT image without AI assistance shows a 12.1-mm spiculated right lower lobe pulmonary nodule. (B) Corresponding CT image with AI-assisted pulmonary nodule detection, automated segmentation, and quantitative nodule assessment identifies a solid pulmonary nodule (nodule #1) measuring 13 × 8 (11) mm, with a volume of 739 mm3, a 45% volumetric increase compared with the previous contrast-enhanced chest CT performed on October 9, 2023 (510 mm3), and an estimated volume doubling time (VDT) of 216 days. (C) AI-generated longitudinal nodule analysis displays automated segmentation of the current (February 2, 2024) and previous (October 9, 2023) CT examinations, 3D nodule reconstruction, and quantitative volumetric assessment for longitudinal follow-up. The AI interface is displayed in the original software language (Dutch).
PCCT on par with MRI for diagnostic breast imaging
By Amerigo Allegretto
PCCT performed similarly to MRI for characterizing breast lesions and finding additional lesions.
September 1, 2026
Detection and extent of BI-RADS suspicious calcifications (amorphous, coarse heterogeneous, fine pleomorphic, and fine linear or fine linear branching) at axial photon-counting CT (PCCT) versus full-field digital mammography (first three images, craniocaudal view; last image, mediolateral oblique view). Calcifications found on mammography showed only partial visualization at ultrahigh-resolution PCCT (0.2 mm), while amorphous calcifications could not be distinguished from image noise. Corresponding abnormal enhancement was clearly depicted on contrast-enhanced PCCT images.
Koning partners with UberDoc marketplace
By AuntMinnie.com staff writers
Koning will display UberDoc physician and service listings within its breast CT platform and introduce provider sites to UberDoc.
September 1, 2026
Ct Scan Patient 400
Is nitroglycerin necessary prior to photon-counting CT?
By Will Morton
Sublingual nitroglycerin is routinely administered before CCTA to induce coronary vasodilation.
August 27, 2026
Representative case from the non-nitroglycerin cohort. A 92-year-old man who did not receive sublingual nitroglycerin because of severe aortic stenosis. The Agatston coronary artery calcium score was 5438. (A) Curved multiplanar reformatted CCTA image reconstructed at 0.4-mm slice thickness using a Bv60 kernel and QIR strength 3 demonstrates diffuse multifocal mild luminal stenoses related to extensive calcified atherosclerotic plaque. (B) Invasive coronary angiography confirmed multifocal mild stenoses without evidence of obstructive coronary artery disease.
Sustainability efforts should look to state power grids
By Amerigo Allegretto
Variation in grid carbon intensity by state drives per-beneficiary greenhouse gas emissions from MRI and CT use.
August 28, 2026
Choropleth map of state-level imaging-associated greenhouse gas emissions per 1,000 Medicare Part B fee-for-service beneficiaries in 2022. Darker shades indicate higher per-beneficiary greenhouse gas emissions. District of Columbia (not shown) is in 3-4 MTCO2e per 1,000 range. MT CO₂e = metric tons of carbon dioxide equivalent
Page 1 of 692
Next Page